Health & Fitness
Wed, August 3, 2011Tue, August 2, 2011Mon, August 1, 2011Sun, July 31, 2011Fri, July 29, 2011Thu, July 28, 2011Wed, July 27, 2011Tue, July 26, 2011Mon, July 25, 2011Sat, July 23, 2011Fri, July 22, 2011Thu, July 21, 2011Wed, July 20, 2011Tue, July 19, 2011Mon, July 18, 2011Fri, July 15, 2011Thu, July 14, 2011Wed, July 13, 2011Tue, July 12, 2011Mon, July 11, 2011Sun, July 10, 2011Sat, July 9, 2011Fri, July 8, 2011The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Icagen, Inc.
Published in Health and Fitness on Wednesday, July 20th 2011 at 10:11 GMT by Market Wire
NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Icagen, Inc. ("Icagen" or the aCompanya) (NASDAQ: ICGN) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pfizer Inc. (NYSE:PFE). Under the terms of the transaction, Icagen shareholders will receive $6.00 per share of Icagen stock they own. Pfizer currently owns approximately 11% of Icagena™s fully diluted shares. The transaction has a total aggregate value of approximately $56 million.
Click here to learn how to join the action: [ http://www.zlk.com/icagen-icgn ], or call: 877-363-5972.
The investigation concerns whether the Icagen Board of Directors breached their fiduciary duties to Icagen stockholders by failing to adequately shop the Company before entering into this transaction and whether Pfizer Inc. is underpaying for Icagen shares, thus unlawfully harming Icagen stockholders. In particular, Icagen stock traded as high as $7.90 as recently as July 18, 2011. Furthermore, at least one analyst set a price target of $8.00 per Icagen share.
If you own common stock in Icagen and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or [ http://www.zlk.com ].
Levi & Korsinsky is a national firm with offices in New York, California and Washington D.C. The firm has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 15th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
[ www.zlk.com ]
